Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Rhythm Biosciences Ltd. ( (AU:RHY) ) is now available.
Rhythm Biosciences has issued 18,834,007 ordinary shares and lodged a cleansing notice under section 708A(5)(e) of the Corporations Act, confirming the shares were issued without a disclosure document and that the company remains compliant with its continuous disclosure and financial reporting obligations. The company also states there is no excluded information that must be disclosed, helping ensure that the newly issued shares can be freely traded and reinforcing transparency for investors within Australia’s regulatory framework.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd is an Australian medical diagnostics company focused on developing simple, affordable blood tests for the accurate and early detection of cancers. Founded in 2017 and headquartered in Melbourne, it aims to improve patient outcomes and reduce the global burden of cancer through early detection, working with global partners to commercialise and distribute its solutions.
Average Trading Volume: 976,474
Technical Sentiment Signal: Buy
Current Market Cap: A$63.87M
Learn more about RHY stock on TipRanks’ Stock Analysis page.